Each country in Europe is investing a considerable amount of effort in, on the one hand, defining a medium and long-term strategy through the adoption and gradual lifting of containment measures, and, on the other hand, minimising the economic impact of the covid-19- related cris...
Vaccines are our best chance to put an end to the COVID-19 pandemic. The European Commission is building one of the broadest portfolios of different vaccines that are safe, effective and affordable. ...
This study is about the effects of air pollution on health, notably COVID-19. The COVID-19 pandemic continues to wreak havoc in many areas of the world. The infection spreads through person-to-person contact. Transmission and prognosis, once infected, are potentially influenced b...
This report provides a cross-cutting view of key health topics in the EU from a gender perspective, analysing the main issues with a specific focus on differences between women and men. Gender is discussed at the level of individual mental and physical health and within healthcar...
The purpose of these guidelines is to ensure compliance with the scope and requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 2004/757/JHA (as amended) in respect to the risk assessment procedure for and reporting on new psychoactive substanc...
The 2020 edition of Health at a Glance: Europe focuses on the impact of the COVID‑19 crisis. Chapter 1 provides an initial assessment of the resilience of European health systems to the COVID‑19 pandemic and their ability to contain and respond to the worst pandemic in the past c...
Over the last decades, a variety of fatal infectious diseases have had zoonotic origins. The linkages between hosts, vectors, parasites and pathogens can be influenced by a multitude of factors, such as biodiversity, wildlife and land use. High levels of biodiversity may be a pot...
This is a one-page summary of the Joint Opinion of the Group of Chief Scientific Advisors, the European Group on Ethics in Science and New Technologies (EGE) and the Special advisor to the Commission President on the response to COVID-19, Professor Peter Piot. ...
The European Commission has been working since June to secure the most promising Covid-19 future vaccines. Now that we have one of the most comprehensive vaccine portfolios in the world, we need to get ready for rapidly granting marketing authorisation to those vaccines. At the s...
